VSIR and multiple sclerosis: Additionally, in a murine model of multiple sclerosis, antibody-mediated VISTA blockade exacerbated the development and disease severity of experimental autoimmune encephalomyelitis (5), which indicates an inhibitory role for the VISTA ligand in vivo.